Nutrition and health

Objectives:
An enhanced risk for cardiovascular disease (CVD) still exists even when patients with type 2 diabetes have tight control on blood sugar. Thus, identification of treatment approaches that address CVD risk factors may be useful for patients beyond the blood sugar management. Although emerging evidence suggests that nuts consumption have beneficial effects on cardiometabolic health, the effects of almond intake in patients with type 2 diabetes are still controversial. Therefore, this review article has been conducted. 

Does almond consumption improve risk factors (cholesterol, triglycerides, fasting plasma glucose, insulin, hemoglobin A1c (HbA1c), body mass index, weight, body fat, systolic and diastolic blood pressure and CRP) of cardiovascular disease in patients with type 2 diabetes?

Study design:
This review article included 9 RCTs.

Results and conclusions:
The investigators found there was a causal relationship between almond dietary intake and a  significant reduction in low-density lipoprotein cholesterol (LDL cholesterol or bad cholesterol) [WMD = -5.28 mg/dL, 95% CI = -9.92 to -0.64, p = 0.026] in patients with type 2 diabetes compared with the control group.
This lowering effect of LDL cholesterol was robust in subgroups with almond consumption >50 g/day and baseline LDL cholesterol level 130 mg/dL.

The investigators found, however, the effect of almond on total cholesterol, triglycerides, high-density lipoprotein cholesterol (HDL cholesterol or good cholesterol), fasting plasma glucose, insulin, HbA1c, body mass index, weight, body fat, systolic and diastolic blood pressure and CRP was not significant compared with the control group.

The investigators concluded that a dietary intake of at least 50 g/d almond decreases causally LDL cholesterol (bad cholesterol) but has no favourable effect on other cardiometabolic outcomes in patients with type 2 diabetes. Further high-quality studies are needed to firmly establish the clinical efficacy of the almond.

Original title:
Effects of almond on cardiometabolic outcomes in patients with type 2 diabetes: A systematic review and meta-analysis of randomized controlled trials by Moosavian SP, Rahimlou M, […], Jalili C.

Link:
https://pubmed.ncbi.nlm.nih.gov/35443097/

Additional information of El Mondo:
Find more information/studies on almond consumption and diabetes right here.
 

Objectives:
While there is growing research interest in the effects of nutrition and exercise on delaying sarcopenia, the results are inconclusive and there is scarce information on regional patterns. Therefore, this review article has been conducted.

Do protein supplements combined with exercise improve extremity strength in healthy older adults with sarcopenia?

Study design:
This review article included 14 RCTs, involving a total of 888 healthy older adults (>60 years).

4 studies in Asian countries provided data on lower-extremity strength, involving 280 participants (138 in protein supplements + exercise group and 142 in exercise group).
Lower-extremity strength was assessed using knee extension (n = 3) or leg extension (n = 1).
The intervention period of all studies was 12 weeks.
The dosage of protein ranged from 3 g/d to 40 g/d.

Results and conclusions:
The investigators found in 4 studies in Asian countries a significant increase in the lower-extremity strength in the protein supplementation + exercise group compared to the exercise group, with a SMD of 0.24 [95% CI = 0.00 to 0.47, p = 0.048, I2 = 0.0%, p = 0.513].

The investigators concluded that protein supplements (3 g/d to 40 g/d during 12 weeks) combined with exercise (knee extension and leg extension) exerts superior benefit on lower-extremity strength in healthy older adults with sarcopenia in Asian countries, when compared to exercise alone or with a placebo. However, no additional benefits from protein supplementation are observed on upper-extremity strength, muscle mass and physical performance regardless of the regions. More well-designed RCTs with information on baseline and total protein intake for longer follow-up periods are warranted to evaluate the effectiveness of protein supplementation and exercise on the prevention and management of sarcopenia in healthy older adults.

Original title:
Effects of protein supplementation and exercise on delaying sarcopenia in healthy older individuals in Asian and non-Asian countries: A systematic review and meta-analysis by Li L, He Y, […], Liu X.

Link:
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8808080/

Additional information of El Mondo:
Find more information/studies on protein and elderly right here.

Upper extremity is part of the body that includes the arm, wrist and hand.

Lower extremity refers to the part of the body from the hip to the toes.

Sarcopenia is a type of muscle loss (muscle atrophy) that occurs with aging and/or immobility. Sarcopenia can affect people in their 30s and beyond.
 

Objectives:
Epidemiological studies indicate that higher intakes of flavonoids are associated with reduced stroke risk. However, which subtypes play significant roles to protect against stroke remain unclear. Therefore, this review article has been conducted.

Does dietary intake of different flavonoid subclasses (flavanones, flavan-3-ols) reduce risk of stroke?

Study design:
This review article included 10 independent prospective cohort studies with 387,076 participants and 9,564 events (persons with stroke).

Results and conclusions:
The investigators found higher intakes of flavanones significantly reduced risk of stroke with 15% [RR = 0.85, 95% CI = 0.78 to 0.93].

The investigators found dose-response analysis showed that 50 mg/day increment of flavanones dietary intake was significantly associated with 11% reduction in stroke risk [RR = 0.89, 95% CI = 0.84 to 0.94].

The investigators found dose-response analysis showed that 200 mg/day increment of flavan-3-ols dietary intake was significantly associated with 14% reduction in stroke risk [RR = 0.86, 95% CI = 0.75 to 0.98].

The investigators found no association with respect to other flavonoid subclasses.

The investigators concluded that both 50 mg/day flavanones and 200 mg/day flavan-3-ols dietary intake reduce stroke risk. The findings of these associations of the present study need to be confirmed in other regions and ethnic origins.

Original title:
A meta-analysis of prospective cohort studies of flavonoid subclasses and stroke risk by Li XQ, Wang C, […], Guo XF.

Link:
https://pubmed.ncbi.nlm.nih.gov/35023220/

Additional information of El Mondo:
Find more information/studies on flavonoid consumption and stroke prevention right here.

Objectives:
Is IL-6 is a candidate marker for severe malaria?

Study design:
This review article included 43 studies.

Most of the included studies were prospective observational studies (19, 44.2%) and the remaining study types included cross-sectional studies (16, 37.2%), case-controlled studies (6, 14%) and randomized controlled trials (RCTs) (2, 4.6%).

The studies enrolled patients with P. falciparum (32, 74.4%), P. vivax (4, 9.3%), P. falciparum/P. vivax (3, 6.98%), P. falciparum/P. knowlesi (1, 2.3%), P. falciparum/P. vivax/P. ovale (1, 2.3%), P. falciparum/P. vivax/mixed infection (1, 2.3%) and P. falciparum/P. vivax/P. ovale/P. malariae (1, 2.3%).

Some studies enrolled children (20, 46.5%), adults (16, 37.2%), all age groups (6, 14%) and not specified (1, 2.3%).

Most of the studies (31, 72.1%) used only microscopy for malaria detection although microscopy/PCR (5, 11.6%), microscopy/rapid diagnostic test (RDT; 5, 11.6%) and microscopy/RDT/PCR (2, 4.65%) were also used.

An ELISA was the most common method used for IL-6 measurements (30, 69.8%), followed by a bead-based assay (13, 30.2%).

Thirty-two studies (74.4%) were high quality, whereas 11 studies were moderate qualities.
Heterogeneity of the effect estimate among the included studies was the main limitation of this analysis.

Results and conclusions:
The investigators found results of the meta-analysis showed that patients with severe malaria had higher mean IL-6 levels than those with non-severe malaria [WMD = 96.63 pg/mL, 95% CI = 0.88 to 19.38 pg/mL, p = 0.04, I2 = 99.9%, 13 studies].

The investigators found that the pooled effect estimate was unchanged after the publication bias was adjusted [WMD = 96.60 pg/mL, 95% CI = 4.32 to 188.89 pg/mL, p = 0.04, 13 studies].

The investigators found results of the meta-analysis showed that patients with uncomplicated malaria had higher mean IL-6 levels than the controls [WMD = 42.86 pg/mL, 95% CI = 30.17 to 55.56 pg/mL, p 0.001, I2 = 100%, 17 studies].

The investigators found results of the meta-analysis showed no differences in the mean levels of IL-6 between patients with uncomplicated malaria and those with asymptomatic malaria [WMD = 42.07 pg/mL, 95% CI = -2.23 pg/mL to -86.37 pg/mL, p = 0.063, I2 = 99.1%, 8 studies] or between patients with asymptomatic malaria and healthy controls [WMD = 1.67 pg/mL, 95% CI = -2.73 pg/mL to -6.07 pg/mL, p = 0.45, I2 = 98.1%, 2 studies].

The investigators found subgroup analysis of continents showed no differences in IL-6 levels between patients with severe malaria and non-severe malaria for studies conducted in Africa and Asia.

The investigators found results of the meta-analysis showed that a higher mean level of IL-6 was observed in patients who died compared with the levels of those who survived [WMD = 1,399.19 pg/mL, 95% CI = 384.16 to  2,414.2 pg/mL, p = 0.007, I2 = 93.1%, 4 studies].

The investigators found meta-regression analyses of continents, malarial complications, parasitemia, age, male percentage, malaria diagnostic methods and IL-6 measurement methods showed that these co-variates did not confound the effect estimate [p > 0.05].

The investigators concluded significantly increased levels of IL-6 are observed in patients with severe malaria compared with those in patients with non-severe malaria, which indicates that IL-6 is a candidate marker for severe malaria. In addition, IL-6 might be a candidate marker for malaria infection and therefore could be used to differentiate malaria infection from other febrile diseases. Therefore, it is recommended that future studies should investigate the sensitivity and specificity of increased IL-6 levels to determine the effectiveness of measuring IL-6 levels to detect malaria infection and monitor malaria severity to improve the efficiency of malaria diagnosis and management.

Original title:
Increased interleukin-6 levels associated with malaria infection and disease severity: a systematic review and meta-analysis by Wilairatana P, Mala W, […], Kotepui M.

Link:
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8993930/

Additional information of El Mondo:
Find more information/studies on food fortification/malnutrition and malaria right here.

Objectives:
Oat supplementation interventions (OSIs) may have a beneficial effect on cardiovascular disease (CVD) risk. However, dietary background can modulate such effect. Therefore, this review article has been conducted.

Does dietary oat supplementation lower levels of blood lipids (cholesterol, triglycerides) and improve anthropometric parameters (glucose level, body mass index, weight, blood pressure, waist circumference) among participants with predominantly mild metabolic disturbances?

Study design:
This review article included 74 RCTs with a total of 4,937 predominantly hypercholesterolemic, obese subjects, with mild metabolic disturbances. Of these, 59 RCTs contributed to the meta-analyses.

The majority of included RCTs (81.1%) had some concerns for risk of bias.

Results and conclusions:
The investigators found oat supplementation (as oat, oat beta-glucan-rich extracts or avenanthramides), compared to control arms without oats, significantly improved levels of:
-total cholesterol (TC) [WMD = -0.42 mmol/L, 95% CI = -0.61 to -0.22];
-LDL cholesterol [WMD = -0.29 mmol/L, 95% CI = -0.37 to -0.20];
-glucose [WMD = -0.25 nmol/L, 95% CI = -0.36 to -0.14];
-body mass index [WMD = -0.13 kg/m², 95% CI = -0.26 to -0.01];
-weight [WMD = -0.94 kg, 95% CI = -1.84 to -0.05] and;
-waist circumference [WMD = -1.06 cm, 95% CI = -1.85 to -0.27].

The investigators found RCTs on inflammation and/or oxidative stress markers were scarce and with inconsistent findings.

The investigators found RCTs comparing an oat supplementation intervention to heterogeneous interventions (e.g., wheat, eggs, rice, etc.), showed lowered levels of glycated haemoglobin, diastolic blood pressure, HDL cholesterol and apolipoprotein B.

The investigators concluded dietary oat supplementation (as oat, oat beta-glucan-rich extracts or avenanthramides) may lower levels of blood lipids and improve anthropometric parameters among obese participants with predominantly mild metabolic disturbances, regardless of dietary background or control. May lower because the majority of included RCTs had some concerns for risk of bias. Therefore, further high-quality trials are warranted to establish the role of oat supplementation intervention on blood pressure, glucose homeostasis and inflammation markers.

Original title:
Effect of oat supplementation interventions on cardiovascular disease risk markers: a systematic review and meta-analysis of randomized controlled trials by Llanaj E, Dejanovic GM, […], Muka T.

Link:
https://pubmed.ncbi.nlm.nih.gov/34977959/

Additional information of El Mondo:
Find more information/studies on oat consumption, overweight and cardiovascular diseases right here.

These products are suitable for persons with cardiovascular diseases.

Objectives:
Is there an association between dietary diversity (DDiv) and growth outcomes (stunting, wasting and underweight) in children aged 5 years?

Study design:
This review article included 70 cross-sectional studies, 4 longitudinal cohort studies, 5 case-control studies and 2 randomized controlled trials.

Of the studies, 45 focused on infants and 36 on children aged 5 years.
The reviewed articles had good quality and low risk of bias (scores >6).

Results and conclusions:
The investigators found in infants, low dietary diversity was significantly associated with stunting, wasting and being underweight [79%, 57% and 68% of the studies, respectively].

The investigators found among children aged 5 years, the association was observed in 75%, 56% and 57% of the studies, respectively, for stunting, wasting and underweight.

The investigators concluded the findings indicate an association between low dietary diversity (DDiv) of infants and children aged 5 years with stunting. However, this association remains uncertain with wasting and being underweight.

Original title:
Association of Dietary Diversity With Growth Outcomes in Infants and Children Aged Under 5 Years: A Systematic Review by Gol RM, Kheirouri S and Alizadeh M.

Link:
https://pubmed.ncbi.nlm.nih.gov/35000681/

Additional information of El Mondo:
Find more information/studies on food fortification/malnutrition right here.

Objectives:
Evidence associating diet with the incidence of renal cell carcinoma (RCC) is inconclusive. Therefore, this umbrella review article has been conducted.

What is the association between diet and renal cell carcinoma incidence?

Study design:
This umbrella review article included 22 meta-analyses with a total of 502 individual studies and 64 summary hazard ratios (HRs) for renal cell carcinoma incidence: dietary patterns or dietary quality indices (n = 6), foods (n = 13), beverages (n = 4), alcohol (n = 7), macronutrients (n =15) and micronutrients (n =19).

No meta-analyses had high methodological quality.

59% of these 502 individual studies were cohort studies (n = 298), 39% were case-control studies (n = 196) and 2% were pooled studies (n = 8).

Sixty (94%) exposures in the included meta-analyses had more than 1,000 cases or 20,000 participants.

Results and conclusions:
The investigators found no dietary factors showed convincing or highly suggestive evidence of association with renal cell carcinoma incidence in the overall analysis.

The investigators found in the overall analysis that dietary intake of vegetables significantly reduced risk of renal cell carcinoma with 26% [summary HR = 0.74, 95% = 0.63 to 0.86, suggestive evidence].

The investigators found in the overall analysis that dietary intake of vitamin C significantly reduced risk of renal cell carcinoma with 23% [summary HR = 0.77, 95% = 0.66 to 0.90, suggestive evidence].

The investigators found in the overall analysis that moderate drinking significantly reduced risk of renal cell carcinoma with 23% [summary HR = 0.77, 95% = 0.70 to 0.84, convincing evidence] in Europe and North America.

The investigators found in the overall analysis that dietary intake cruciferous vegetables significantly reduced risk of renal cell carcinoma with 22% [summary HR = 0.78, 95% = 0.70 to 0.86, highly suggestive evidence] in North America.

The investigators concluded dietary intake of vegetables and vitamin C could reduce renal cell carcinoma risk. Moderate drinking might be beneficial for Europeans and North Americans and cruciferous vegetables might be beneficial to North Americans, but the results should be interpreted with caution because no meta-analyses had high methodological quality. More researches are needed in the future.

Original title:
The role of diet in renal cell carcinoma incidence: an umbrella review of meta-analyses of observational studies by Liao Z, Fang Z, […], Luo Z.

Link:
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8812002/

Additional information of El Mondo:
Find more information/studies on cancer, vegetables, vitamin C right here.

An umbrella review article is a scientific article which only includes meta-analyses (also called review articles). The results found in an umbrella review article are more reliable than found in an individual review article.

One swallow does not make a summer. A famous Dutch saying that could not be any more obvious. Just because one single scientific study about a certain topic makes certain claims, it does not necessarily mean it is true. On the other hand, a review article (a collection of scientific studies on a certain topic) of randomized, placebo-controlled double blind clinical trials (RCTs) will answer the following question:
"Do taking dietary supplements make sense?" Yes for a positive conclusion and no for a negative conclusion.

One swallow does not make a summer. A famous Dutch saying that could not be any more obvious. Just because one single scientific study about a certain topic makes certain claims, it does not necessarily mean it is true. On the other hand, a review article (a collection of scientific studies on a certain topic) of (prospective) cohort studies or case-control studies will answer the following question:
"Should I change my diet?".

Objectives:
There is currently a lack of high-quality research on the best dietary recommendations for patients with early glaucoma or at high risk for glaucoma. Therefore, this review article has been conducted.

Does a high dietary vitamin intake reduce risk of glaucoma?

Study design:
This review article included 8 cohort studies, with a total of 262,189 patients.

There was no publication bias.

Results and conclusions:
The investigators found that high-dose dietary intake of vitamins A was significantly associated with a 27% low risk of glaucoma [OR = 0.63, 95% CI = 0.53 to 0.76 , p 001, I2 = 49%].

The investigators found that high-dose dietary intake of vitamins B (a combination of B1, B2, B3, B6 and B12) was significantly associated with a 29% low risk of glaucoma [OR = 0.71, 95% CI = 0.64 to 0.80, p 0.001, I2 = 29%].

The investigators found no association between high-dose dietary intake of vitamins C, D or E and lower risk of glaucoma.

The investigators concluded that high-dose dietary intake of vitamins A and B, but not vitamins C, D or E, is associated with a low prevalence of glaucoma. Overall, middle-aged and elderly people or patients with early glaucoma should consume vitamin-rich foods rich or take additional vitamin supplements.

Original title:
Vitamin intake and glaucoma risk: A systematic review and meta-analysis by Han FF and Fu XX.             

Link:
https://www.sciencedirect.com/science/article/pii/S0181551222000419?via%3Dihub

Additional information of El Mondo:
Find here more information/studies about chronic diseases, vitamin A and B.
 

Objectives:
There is some evidence regarding the positive effects of ginger supplementation on metabolic profile in patients with type 2 diabetes (T2DM). However, they are conflicting and therefore, this review article has been conducted. 

Does ginger supplementation improve metabolic profile (FBS, HbA1c, TC, TG, LDL, HDL, SBP and DBP) in patients with type 2 diabetes?

Study design:
This review article included 10 RCTs.

Results and conclusions:
The investigators found pooled meta-analysis showed a significant reduction in fasting blood sugar (FBS) level following ginger supplementation by polling 8 effect sizes [WMD = -18.81, 95% CI = -28.70 to -8.92, I2 = 77.4%].

The investigators found pooled meta-analysis showed a significant reduction in HbA1c level following ginger supplementation by polling 7 effect sizes [WMD = -0.57, 95% CI = -0.93 to -0.20, I2 = 88.6%].

The investigators found pooled meta-analysis showed a significant reduction in systolic blood pressure (SBP) following ginger supplementation by polling 5 effect sizes [WMD = -4.20, 95% CI = -7.64 to -0.77, I2 = 97%].

The investigators found pooled meta-analysis showed a significant reduction in diastolic blood pressure (DBP) following ginger supplementation by polling 5 effect sizes [WMD = -1.61, 95% CI = -3.04 to -0.18, I2 = 93.2%].

The investigators found pooled meta-analysis showed ginger supplementation had no significant influence on lipid profile involving triglyceride (TG), total cholesterol (TC), LDL cholesterol and HDL cholesterol.

The investigators concluded supplementation with ginger reduces fasting blood sugar, HbA1c, systolic blood pressure and diastolic blood pressure in patients with type 2 diabetes. Further large RCTs are required to shed light on this issue.

Original title:
The effect of ginger supplementation on metabolic profiles in patients with type 2 diabetes mellitus: A systematic review and meta-analysis of randomized controlled trials by Ebrahimzadeh A, Ebrahimzadeh A, […], Milajerdi A.

Link:
https://pubmed.ncbi.nlm.nih.gov/35031435/

Additional information of El Mondo:
Find more information/studies on lowering blood pressure and diabetes right here.
 

Objectives:
Does a high serum vitamin D level reduce risk of latent tuberculosis infection?

Study design:
This review article included 2 case-control studies and 3 cohort studies with a total of 1,516 subjects, comprising 117 latent tuberculosis infection (LTBI) patients.
Diagnosis of LTBI in all studies was based upon QFN-GIT, IGRAs and/or TST.
2 case-control and 3 cohort studies were considered as high quality.

Between-studies heterogeneity varied from none to small for the meta-analyses with I2 values ranging from 64.5 to 75.7%. However, sensitivity analysis and visual inspection of funnel plots for checking asymmetry and publication bias weren’t done because only 2 articles were included in association of vitamin D and the risk of LTBI and 3 in association of vitamin D and the incidence of LTBI.

Results and conclusions:
The investigators found in a pooled analysis of 2 case-control studies with 41 LTBI cases and 142 control subjects, that relatively high serum vitamin D level was not significantly associated with a decreased risk of latent tuberculosis infection [OR = 0.51, 95% CI = 0.05 to 5.65, p = 0.58, I2 = 64.5%].
Not significantly because the calculated p-value of 0.58 was larger than the p-value of 0.05.

The investigators found in a pooled analysis of 3 cohort studies involving 1,333 participants, that relatively high serum vitamin D levels did not reduce the incidence of latent tuberculosis infection [RR = 0.56, 95% CI = 0.19 to 1.67, p = 0.300, I2 = 75.7%].

The investigators concluded that serum vitamin D levels are not associated with incidence of latent tuberculosis infection and relatively high serum vitamin D level is not a protective factor for latent tuberculosis infection. Further RCTs are needed to verify whether sufficient vitamin D levels and vitamin D supplementation prevents latent tuberculosis infection.

Original title:
Vitamin D and the risk of latent tuberculosis infection: a systematic review and meta-analysis by Cao Y, Wang X, […], Du J.

Link:
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8772077/

Additional information of El Mondo:
Find more information/studies on food fortification/malnutrition and vitamin D right here.

Objectives:
Does a high olive oil consumption reduce cancer risk?

Study design:
This review article included 37 case-control studies with 17,369 cases (persons with cancer) and 28,294 controls (persons without cancer) and 8 cohort studies with 12,461 incident cases among 929,771 subjects (participants).

Significant publication bias was detected via Egger’s test in the analysis on overall cancer risk [p 0.001], breast cancer [p = 0.013] and gastrointestinal cancer risk [p = 0.048].

Results and conclusions:
The investigators found in pooled analysis of case-control and cohort studies that highest olive oil consumption was significantly associated with a 31% lower risk of any cancer [pooled RR = 0.69, 95% CI = 0.62 to 0.77].  
Significantly means that there is an association with a 95% confidence.

The investigators found subgroup analyses showed that the protective effect of high olive oil consumption in terms of cancer risk was also significant in case-control studies [37 study arms, RR = 0.65, 95% CI = 0.57 to 0.74] but not in cohort studies [8 study arms, RR = 0.90, 95% CI = 0.77 to 1.05].
Furthermore, the protective association was also found in a multivariate analysis [32 study arms, RR = 0.72, 95% CI = 0.65 to 0.81], a high study quality analysis [RR = 0.72, 95% CI = 0.64 to 0.81], Mediterranean participants [RR = 0.69, 95% CI = 0.60 to 0.79] and non-Mediterranean participants [RR = 0.49, 95% CI = 0.34 to 0.71].

The investigators found in pooled analysis of case-control and cohort studies that highest olive oil consumption was significantly associated with a 33% lower risk of breast cancer [pooled RR = 0.67, 95% CI = 0.52 to 0.86].  
Significantly because RR of 1 was not found in the 95% CI of 0.52 to 0.86. RR of 1 means no risk/association.

The investigators found subgroup analyses showed that the beneficial effect was reproducible in case-control studies [RR = 0.63, 95% CI = 0.45 to 0.87] but not in cohort studies.
Furthermore, high olive oil consumption was linked to a reduced breast cancer risk in Mediterranean [RR = 0.67, 95% CI = 0.49 to 0.92] and non-Mediterranean populations [RR = 0.25, 95% CI = 0.07 to 0.89].

The investigators found in pooled analysis of case-control and cohort studies that highest olive oil consumption was significantly associated with a 23% lower risk of gastrointestinal cancer [pooled RR = 0.77, 95% CI = 0.66 to 0.89].  
Subgroup analyses showed an inverse relationship between highest olive oil consumption and risk for esophageal cancer [RR = 0.47, 95%CI = 0.24 to 0.93] and pancreatic cancer [RR = 0.58, 95% CI = 0.35 to 0.97].
Furthermore, significant effects were also found in case-control studies [RR = 0.72, 95% CI = 0.61 to 0.85), studies within the Mediterranean area [RR = 0.77, 95% CI = 0.67 to 0.88], multivariate analyses [RR = 0.76, 95% CI = 0.63 to 0.90] and high quality studies [RR = 0.73, 95% CI = 0.62 to 0.86].

The investigators found in pooled analysis of case-control and cohort studies that highest olive oil consumption was significantly associated with a 26% lower risk of upper aerodigestive cancer [pooled RR = 0.74, 95% CI = 0.60 to 0.91].  
Subgroup analyses showed results remained significant for case-control studies [RR = 0.74, 95% CI = 0.60 to 0.91], multivariate analyses [RR = 0.75, 95% CI = 0.66 to 0.86] and studies of high quality [RR = 0.68, 95% CI = 0.52 to 0.89].

The investigators found in pooled analysis of case-control studies that highest olive oil consumption was significantly associated with a 54% lower risk of urinary tract cancer [pooled RR = 0.46, 95% CI = 0.29 to 0.72].  
Subgroup analyses showed results remained significant for studies of high quality [RR = 0.46, 95% CI = 0.32 to 0.66].

The investigators concluded highest versus lowest olive oil consumption is associated with 31% lower cancer risk, especially for breast, overall gastrointestinal, upper aerodigestive and urinary tract cancer. Additional prospective cohort studies on various cancer types, especially in non-Mediterranean regions, as well as large randomized trials, seem desirable in order to provide further insight into the role of olive oil in preventing cancer.

Original title:
Olive oil intake and cancer risk: A systematic review and meta-analysis by Markellos C, Ourailidou ME, […], Psaltopoulout T.

Link:
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8751986/

Additional information of El Mondo:
Find more information/studies on cancer, olive oil consumption right here.

The conclusions in scientific studies are even more reliable when they are also found in cohort studies, multivariate analyzes (studies where adjustments were made for multiple confounding factors) and high-quality studies.
 

Objectives:
Severe hypertension in pregnancy is a hypertensive crisis that requires urgent and intensive care due to its high maternal and fetal mortality. However, there is still a conflict of opinion on the recommendations of antihypertensive therapy.

What are the optimal blood pressure (BP) levels to prevent severe hypertension in pregnant women with nonsevere hypertension?

Study design:
This review article included 40 RCTs with 6,355 patients.

Results and conclusions:
The investigators found blood pressure lowering treatment significantly lowered risk of severe hypertension with 54% [RR = 0.46, 95% CI = 0.37 to 0.56], preeclampsia with 18% [RR = 0.82, 95% CI = 0.69 to 0.98], severe preeclampsia with 62% [RR = 0.38, 95% CI = 0.17 to 0.84], placental abruption with 48% [RR = 0.52, 95% CI = 0.32 to 0.86] and preterm birth with 19% [37 weeks: RR = 0.81, 95% CI = 0.71 to 0.93], while the risk of small for gestational age infants was significantly increased with 25% [RR = 1.25, 95% CI = 1.02 to 1.54].

The investigators found an achieved systolic blood pressure (SBP) of 130 mmHg significantly reduced the risk of severe hypertension to nearly one-third compared with a systolic blood pressure of ≥140 mmHg, with a significant interaction of the blood pressure levels achieved with BP-lowering therapy.

The investigators found there was no significant interaction between the subtypes of hypertensive disorders of pregnancy and blood pressure lowering treatment, except for placental abruption.

The investigators concluded blood pressure lowering treatment aimed at a systolic blood pressure 130 mmHg and accompanied by the careful monitoring of fetal growth should be recommended to prevent severe hypertension in pregnant women with nonsevere hypertension.

Original title:
Optimal blood pressure target to prevent severe hypertension in pregnancy: A systematic review and meta-analysis by Abe M, Arima H, […], Mukoyama M.

Link:
https://pubmed.ncbi.nlm.nih.gov/35136186/

Additional information of El Mondo:
Find more information/studies on food fortification/malnutrition and pregnancy right here.

Objectives:
Does a higher intake of dietary antioxidants (like vitamin C and E, β-carotene, zinc, anthocyanins, lutein) reduce risk of Parkinson's disease (PD)?

Study design:
This review article included 6 prospective cohort studies and 2 nested case-control studies (448,737 participants with 4,654 persons with Parkinson's disease) and 6 case-control studies (1,948 persons without Parkinson's disease and 1, 273 persons with Parkinson's disease).

Results and conclusions:
The investigators found comparded to the lowest dietary vitamine E intake, that the highest dietary vitamine E intake significantly reduced risk of Parkinson's disease with 16% [pooled RR = 0.84, 95% CI = 0.71 to 0.99, n = 7 cohort studies].
Significantly means that there is an association with a 95% confidence.

The investigators found compared to the lowest dietary anthocyanins intake, that the highest dietary anthocyanins intake significantly reduced risk of Parkinson's disease with 24% [pooled RR = 0.76, 95% CI = 0.61 to 0.96, n = 2 cohort studies].
Significantly because pooled RR of 1 was not found in the 95% CI of 0.61 to 0.96. RR of 1 means no risk/association.

The investigators found compared to the lowest dietary lutein intake, that the highest dietary lutein intake significantly increased risk of Parkinson's disease with 86% [pooled RR = 1.86, 95% CI = 1.20 to 2.88, n = 3 case-control studies].

The investigators found in dose-response meta-analyses that every increment of dietary vitamin C intake with 50 mg/d significantly reduced risk of Parkinson's disease with 6% [RR = 0.94, 95% CI = 0.88 to 0.99, n = 6].

The investigators found in dose-response meta-analyses that every increment of dietary vitamin E intake with 5 mg/d significantly reduced risk of Parkinson's disease with 16% [RR = 0.84, 95% CI = 0.70 to 0.99, n = 7].

The investigators found in dose-response meta-analyses that every increment of dietary β-carotene intake with 2 mg/d significantly reduced risk of Parkinson's disease with 6% [RR = 0.94, 95% CI = 0.89 to 0.99, n = 6].

The investigators found in dose-response meta-analyses that every increment of dietary zinc intake with 1 mg/d significantly reduced risk of Parkinson's disease with 35% [RR = 0.65, 95% CI = 0.49 to 0.86, n = 1].

The investigators concluded that higher intake of antioxidant-rich foods reduces risk of Parkinson's disease. Future, well-designed prospective studies are needed to validate the present findings.

Original title:
Dietary Antioxidants and Risk of Parkinson's Disease: A Systematic Review and Dose-response Meta-analysis of Observational Studies by Talebi S, Ghoreishy SM, […], Mohammadi H.

Link:
https://pubmed.ncbi.nlm.nih.gov/35030236/

Additional information of El Mondo:
Find here more information/studies about RCTs/significant and antioxidants.
 

Objectives:
Does postoperative coffee or caffeine consumption causally reduce risk of postoperative ileus (POI) in patients undergoing elective colorectal surgery?

Study design:
This review article included 4 RCTs with 312 subjects.

Results and conclusions:
The investigators found postoperative coffee or caffeine consumption significantly decreased the time to first bowel movement [MD = -10.36 h, 95% CI = -14.61 to -6.11], shortened the length of hospital stay [MD = -0.95 days, 95% CI = -1.57 to -0.34] and was significantly  associated with a 36%-decreased risk of the use of any laxatives after the procedure [RR = 0.64, 95% CI = 0.44 to 0.92].

The investigators found the time to first flatus, time to tolerance of solid food, risk of any postoperative complication, postoperative reinsertion of a nasogastric (NG) tube and anastomotic leakage showed no statistical differences between groups.

The investigators concluded postoperative coffee or caffeine consumption causally improves bowel movement and decreases the duration of hospital stay in patients undergoing elective colorectal surgery. This method is safe and can prevent or treat postoperative ileus (POI).

Original title:
The effect of coffee/caffeine on postoperative ileus following elective colorectal surgery: a meta-analysis of randomized controlled trials by Yang TW, Wang CT, […], Tsai MC.

Link:
https://pubmed.ncbi.nlm.nih.gov/34993568/

Additional information of El Mondo:
Find more information/studies on caffeine and cancer right here.

Postoperative ileus is a prolonged absence of bowel function after surgical procedures, usually abdominal surgery.

Objectives:
What is the safety of dihydroartemisinin-piperaquine (DHA-PQ) compared to artemether-lumefantrine (AL) for the treatment of uncomplicated P. falciparum malaria among children in Africa?

Study design:
This review article included 18 studies involving 10,498 African children with uncomplicated P. falciparum malaria.

A target dose (range) of 4 (2-10) mg/kg bw per day dihydroartemisinin and 18 (16-27) mg/kg bw per day piperaquine given once a day for 3 days for children weighing ≥25 kg.
The target doses and ranges for children weighing 25 kg are 4 (2.5-10) mg/kg bw per day dihydroartemisinin and 24 (20-32) mg/kg bw per day piperaquine once a day for 3 days.

Results and conclusions:
The investigators found, compared to AL, DHA-PQ significantly increased frequency of early vomiting with 126% [RR = 2.26, 95% CI = 1.46 to 3.50, I2 = 0%, participants = 7,796, studies = 10, high quality of evidence].

The investigators found, compared to AL, DHA-PQ significantly increased frequency of cough with 6% [RR = 1.06, 95% CI = 1.01 to 1.11, I2 = 0%, participants = 8,013, studies = 13, high quality of evidence].

The investigators found, compared to AL, DHA-PQ significantly increased frequency of diarrhoea with 16% [RR = 1.16, 95% CI = 1.03 to 1.31, I2 = 8%, participants = 6,841, studies = 11, high quality of evidence].

The investigators concluded that both drugs are well tolerated by children. There are comparable occurrences of adverse events in both treatment arms. But, early vomiting, diarrhoea and cough are common and more frequent in African children who are treated with the DHA-PQ than that of AL (high quality of evidence). All serious adverse events are consistent with malaria symptoms and judged to be unrelated to study medication. More studies comparing AL with DHA-PQ are needed to determine the comparative safety of these drugs.

Original title:
Safety of dihydroartemisinin-piperaquine versus artemether-lumefantrine for the treatment of uncomplicated Plasmodium falciparum malaria among children in Africa: a systematic review and meta-analysis of randomized control trials by Assefa DG, Zeleke ED, […], Makonnen E.

Link:
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8725395/

Additional information of El Mondo:
Find more information/studies on food fortification/malnutrition and malaria right here.

Objectives:
Lung cancer is the most common cause of cancer death. Fruits and vegetables containing carotenoids and other antioxidants have been hypothesized to decrease lung cancer risk. Therefore, this meta-analysis (systematic review) has been conducted.

Do fruits and vegetables reduce lung cancer risk?

Study design:
This review article included prospective cohort studies up to December 2014.

Results and conclusions:
The investigators found in 18 studies, when comparing the highest fruits and vegetables with the lowest intakes, a significantly reduced risk of 14% for lung cancer [summary RR = 0.86 [95% CI = 0.78-0.94].

The investigators found in 25 studies, when comparing the highest vegetables with the lowest intakes, a significantly reduced risk of 8% for lung cancer [summary RR = 0.92 [95% CI = 0.87-0.97].

The investigators found in 29 studies, when comparing the highest fruits with the lowest intakes, a significantly reduced risk of 18% for lung cancer [summary RR = 0.82, 95% CI = 0.76-0.89].

The investigators found the association with fruit and vegetable intake was marginally significant in current smokers and inverse but not significant in former or never smokers.

The investigators found in 4 studies for each 100 g/day increase of fruits and vegetables, a significantly reduced risk of 4% for lung cancer [RR = 0.96, 95% CI = 0.94-0.98, I2 = 64%, n (cases) = 9,609].

The investigators found in 20 studies for each 100 g/day increase of vegetables, a significantly reduced risk of 6% for lung cancer [RR = 0.94, 95% CI = 0.89-0.98, I2 = 48%, n (cases) = 12,563].

The investigators found in 23 studies for each 100 g/day increase of fruits, a significantly reduced risk of 8% for lung cancer [RR = 0.92, 95% CI = 0.89-0.95, I2 = 57%, n (cases) = 14,506].

The investigators found the results were consistent among the different types of fruits and vegetables. However, the strength of the association differed across locations.

The investigators found evidence of a non-linear relationship [p 0.01] between fruit and vegetable intake and lung cancer risk showing that no further benefit is obtained when increasing consumption above ∼400g per day.

The investigators concluded fruits and/or vegetables intakes reduce risk of lung cancer with no further benefit when increasing consumption of fruits and vegetables above ∼400g per day.

Original title:
Fruits, vegetables and lung cancer risk: a systematic review and meta-analysis by Vieira AR, Abar L, […], Norat T.

Link:
http://www.ncbi.nlm.nih.gov/pubmed/26371287

Additional information of El Mondo:
Find more information/studies on fruits and vegetables consumption and cancer right here.

Objectives:
The aim of this review article (meta-analysis) was to assess the clinical efficacy and safety of oral ginger for symptomatic treatment of osteoarthritis (OA).

Study design:
This review article included 5 RCTs with in total 593 patients.

The average age of the patients ranged from 47 years to 66 years and the percentage of women included in the studies ranged from 26% to 80%.
The dose of oral administration of ginger ranged from 500 mg/day to 1000 mg/day.
Trial duration ranged from 3 to 12 weeks.

Results and conclusions:
The investigators found compared to placebo, ginger intake significantly reduced pain [SMD = -0.30, 95% CI = -0.50 to -0.09, p = 0.005, I2 = 27%].

The investigators found compared to placebo, ginger intake showed a statistically significant reduction in disability [SMD = -0.22, 95% CI = -0.39 to -0.04, p = 0.01, I2 = 0%].

The investigators found patients given ginger were more than twice as likely to discontinue (due to adverse events) treatment compared to placebo [RR = 2.33, 95% CI = 1.04 to 5.22, p = 0.04, I2 = 0%].

The investigators concluded that 500-1000 mg/day oral ginger intake is able to reduce pain and disability in osteoarthritis patients.

Original title:
Efficacy and safety of ginger in osteoarthritis patients: a meta-analysis of randomized placebo-controlled trials by Bartels EM, Folmer VN, […], Christensen R.

Link:
http://www.oarsijournal.com/article/S1063-4584(14)01276-X/pdf

Additional information of El Mondo:
Find more information/studies on chronic diseases right here. 

Objectives:
The aim of this review article was to evaluate the diagnostic accuracy of ultrasound in assessing active Crohn’s disease (CD) in adults.

Study design:
This meta-analysis included 15 studies involving 1558 adults with active Crohn’s disease.

Results and conclusions:
The investigators found overall, the pooled sensitivity (0.88) and LR- (0.14) were not heterogeneous, whereas the pooled specificity [0.97, I2 = 72.9%] and LR + [15.10, I2 = 71.8 %] were.

The investigators found the DOR of ultrasound for assessing active CD was 121.70, with significant heterogeneity (I2 = 63.3%).
A symmetrical summary ROC curve was plotted showing that the area under the curve was 0.94, indicating good diagnostic accuracy.

The investigators found meta-regression and subgroup analysis showed that the disease location may be a major cause of heterogeneity.

The investigators concluded ultrasound has high diagnostic accuracy in detecting active Crohn’s disease in adults, especially for small bowel Crohn’s disease.

Original title:
Ultrasound as a diagnostic tool in detecting active Crohn’s disease: a meta-analysis of prospective studies by Dong J, Wang H, [...], Li J.

Link:
http://link.springer.com/article/10.1007/s00330-013-2973-0

Additional information of El Mondo:
Find more information/studies on chronic diseases right here. 

Objectives:
Does allium vegetable consumption reduce gastric cancer risk?

Study design:
This review article included 22 case-control and 4 cohort studies with more than 10,000 cases.

Results and conclusions:
The investigators found in 10 case-control and 4 cohort studies for the highest versus lowest allium vegetables intake category a significant reduced risk of 22% for gastric cancer [OR = 0.78, 95% CI = 0.67-0.91].

The investigators found in 12 case-control studies for the highest versus lowest garlic intake category a significant reduced risk of 40% for gastric cancer [OR = 0.60, 95% CI = 0.47-0.76].

The investigators found in 13 case-control studies for the highest versus lowest onion intake category a significant reduced risk of 45% for gastric cancer [OR = 0.55, 95% CI = 0.41-0.73].

The investigators found in 4 cohort studies for the highest versus lowest allium vegetables intake category a non-significant increased risk of 2% for gastric cancer [RR = 1.02, 95% CI = 0.88-1.18]. Non-significant means no association with 95% confidence.

The investigators concluded high allium vegetable consumption, like garlic and onion is likely to reduce gastric cancer risk. Likely because this evidence is derived mainly from case-control studies. Therefore, further data from large cohorts are desirable for conclusive confirmation.

Original title:
Allium vegetable intake and gastric cancer: a case-control study and meta-analysis by Turati F, Pelucchi C, […], Galeone C.

Link:
https://www.ncbi.nlm.nih.gov/pubmed/25215621

Additional information of El Mondo:
Find more studies/information on allium vegetable consumption and cancer right here.

Objectives:
Garlic is a common spicy flavouring agent also used for certain therapeutic purposes. Garlic's effects on blood glucose have been the subject of many clinical and animal studies. However, studies reporting hypoglycemic effects of garlic in humans are conflicting. Therefore, this review article (meta-analysis) has been conducted.

Has garlic supplementation lowering effects on glycemic control measurements such as fasting blood glucose (FBG), postprandial glucose (PPG) and glycated haemoglobin (HbA1c)?

Study design:
This review article included a total of 7 RCTs (parallel design) that involved 9 comparisons with 513 subjects. The trials varied in size from 33 to 180 subjects. The study duration varied from 4 to 24 week (median: 12 week). The trials enrolled male and female subjects, both healthy and with diabetes.

Doses of garlic in the treatment group ranged from 600 to 1500 mg/d.

Results and conclusions:
The investigators found pooled analyses showed that garlic supplementation resulted in a statistically significant lowering in fasting blood glucose [SMD = -1.67, 95% CI = -2.80 to -0.55, p = 0.004].

The investigators could not perform a pooled analyse for postprandial glucose (PPG) control and glycosylated haemoglobin (HbA1c) outcomes, because only 1 study included in the meta-analysis reported PPG variables and only 2 studies reported HbA1c variables.

The investigators concluded that garlic supplementation (600 to 1500 mg/d) during 12 weeks results in a lowering in fasting blood glucose. More trials are needed to investigate the effectiveness of garlic on HbA1c and PPG.

Original title:
Garlic intake lowers fasting blood glucose: meta-analysis of randomized controlled trials by Hou LQ, Liu YH and Zhang YY.

Link:
http://apjcn.nhri.org.tw/server/APJCN/24/4/575.pdf

Additional information of El Mondo:
Find more information/studies on diabetes and garlic right here.

Objectives:
Emerging randomized controlled trials (RCTs) investigating the effect of green tea or green tea extract (GTE) supplementation on blood pressure (BP) among overweight and obese adults reported inconsistent findings. Therefore, this review article has been conducted.

Does tea consumption decrease blood pressure among overweight and obese adults?

Study design:
This review article included 14 RCTs with 971 participants (47% women).

Results and conclusions:
The investigators found green tea or green tea extract supplementation compared with placebo, significantly reduced systolic blood pressure with 1.42 mmHg [95% CI = -2.47 to -0.36, p  =  0.008, I2  =  52%, p for heterogeneity =  0.01 ] among overweight and obese adults.

The investigators found green tea or green tea extract supplementation compared with placebo, significantly reduced diastolic blood pressure with 1.25 mmHg [95% CI = -2.32 to -0.19, p = 0.02, I2 = 74%, p for heterogeneity   0.001] among overweight and obese adults.

The investigators found the quality of evidence across studies was low. Similar results were found in subgroup and sensitivity analyses.

The investigators concluded among overweight and obese adults, green tea or green tea extract supplementation is found to cause a small but significant reduction in blood pressure. However, more high-quality RCTs with large sample sizes are needed to further confirm the efficacy on blood pressure and make strong recommendations for green tea or green tea extract supplementation among the overweight and obese adults.

Original title:
Effect of green tea supplementation on blood pressure among overweight and obese adults: a systematic review and meta-analysis by Li G, Zhang Y, […], Holbrook A.

Link:
http://journals.lww.com/jhypertension/Abstract/2015/02000/Effect_of_green_tea_supplementation_on_blood.6.aspx

Additional information of El Mondo:
Find more information/studies on tea consumption right here.

Objectives:
There are conflicting reports on the correlation between manganese (Mn) levels and breast cancer. Therefore, this review article (meta-analysis) has been conducted.

Does manganese deficiency increase risk of breast cancer?

Study design:
This review article included 11 case-control studies involving 1302 subjects.

There was no evidence of publication bias. Sensitivity analysis showed that excluding any one study from the pooled analysis did not vary the results substantially.

Results and conclusions:
The investigators found the random-effects meta-analysis results indicated that subjects with breast cancer had lower manganese levels in serum and hair than healthy controls [SMD = -1.51, 95% CI = -2.47 to -0.56, I2 = 97.8%, p 0.001].

The investigators found in subgroup analysis that subjects with breast cancer had lower manganese levels than healthy controls in China [SMD = -1.32, 95% CI = -2.33 to -0.32] and Korea [SMD = -4.08, 95% CI = -4.63 to -3.54], but not in Turkey [SMD = -0.96, 95% CI = -3.19 to 1.27].

The investigators found in subgroup analysis that the differences of manganese levels between patients with breast cancer and healthy controls were similar in different sample specimens:
serum [SMD = -1.24, 95% CI = -2.31 to -0.16];
hair [SMD = -1.99, 95% CI = -3.91 to -0.06] and;
different types of manganese measurement:

ICP-AAS [SMD = -1.14, 95% CI = -2.24 to -0.04];
GFAAS [SMD = -1.94, 95% CI = -2.38 to -1.49];
ICP-AES [SMD = -3.77, 95% CI = -4.70 to -2.85]. These findings can well explain that  the between-study variability was the main source of heterogeneity.

The investigators concluded there is an association between deficient manganese concentration and breast cancer. However, the subgroup analysis found that there was contradiction regarding races and geography, like China and Turkey. Thus this finding needs further confirmation by trans-regional multicenter, long-term observation in a cohort design to obtain better understanding of causal relationships between manganese levels and breast cancer, through measuring manganese at baseline to investigate whether the highest manganese category versus lowest was associated with breast cancer risk.

Original title:
The association between deficient manganese levels and breast cancer: a meta-analysis by Shen F, Cai WS, [...],Xu B.

Link:
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4443096/

Additional information of El Mondo:
Find more studies/information on manganese and breast cancer right here.

Objectives:
Approximately 5.7 million Americans carry the diagnosis of systolic heart failure (HF), a major health care burden. Heart failure is a known manifestation of thiamine deficiency (TD). Therefore, this review article has been conducted.

Is thiamine deficiency (vitamin B1 deficiency) a risk factor of systolic heart failure?

Study design:
This review article included 9 studies (observational studies and RCTs).

Results and conclusions:
The investigators found systolic heart failure patients had a higher risk of 153% of getting a thiamine deficiency [odds ratio = 2.53, 95% CI = 1.65-3.87].

The investigators found diuretic use, changes in dietary habits and altered thiamine absorption and metabolism were identified as possible mechanisms of thiamine deficiency in heart failure patients.

The investigators found small observational studies and randomized control trials suggested that thiamine supplementation in heart failure population could improve ejection fraction and reduce symptoms.

The investigators concluded thiamine deficiency is more prevalent in heart failure population, and its supplementation may be beneficial. The therapeutic role of thiamine in heart failure warrants further study.

Original title:
Determining the Role of Thiamine Deficiency in Systolic Heart Failure: A Meta-Analysis and Systematic Review by Jain A, Mehta R, […], Winchester DE.

Link:
https://www.ncbi.nlm.nih.gov/pubmed/26497757

Additional information of El Mondo:
Find more information/studies on cardiovascular disease and vitamin B1 (thiamine) right here.

Objectives:
Is there an association of intake of different vitamins and multiple-vitamin supplements and the incidence of colorectal cancer?

Study design:
This review article included 47 articles (cohort studies).

There was unacceptable heterogeneity for studies of multiple-vitamin supplements, so findings were inconclusive.

Results and conclusions:
The investigators found a significant reduced risk of 12% [multivariable-adjusted RR = 0.88, 95% CI = 0.81-0.95] for colorectal cancer when comparing the highest versus lowest dietary vitamin B9 (folate) intake. Significant means that there is an association with a 95% confidence.

The investigators found a significant reduced risk of 13% [multivariable-adjusted RR = 0.87, 95% CI = 0.77-0.99] for colorectal cancer when comparing the highest versus lowest dietary vitamin D intake. Significant because RR of 1 was not found in the 95% CI of 0.77 to 0.99. RR of 1 means no risk/association.

The investigators found a significant reduced risk of 12% [multivariable-adjusted RR = 0.88, 95% CI = 0.79-0.99] for colorectal cancer when comparing the highest versus lowest dietary vitamin B6 intake.

The investigators found a significant reduced risk of 14% [multivariable-adjusted RR = 0.86, 95% CI = 0.76-0.97] for colorectal cancer when comparing the highest versus lowest dietary vitamin B2 intake.

The investigators found, however, no association between both dietary vitamine A, C, E, B3 and B12 and the risk of colorectal cancer.

The investigators concluded high dietary vitamin B9 (folate), D, B6 and B2 intake reduces risk of colorectal cancer, but further study is needed.

Original title:
Vitamin and multiple-vitamin supplement intake and incidence of colorectal cancer: a meta-analysis of cohort studies by Liu Y, Yu Q, […], Li K.

Link:
https://www.ncbi.nlm.nih.gov/pubmed/25491145

Additional information of El Mondo:
Find more studies/information on vitamines and colorectal cancer right here.

Objectives:
Red meat intake has been associated with risk of colorectal cancer, potentially mediated through heterocyclic amines. The metabolic efficiency of N-acetyltransferase 2 (NAT2) required for the metabolic activation of such amines is influenced by genetic variation. The interaction between red meat intake, NAT2 genotype and colorectal cancer has been inconsistently reported. Therefore, this review article has been conducted.

Is there an interaction between red meat intake, NAT2 genotype and colorectal cancer?

Study design:
This review article included 11 retrospective case-control studies with 8,290 colorectal cancer cases and 9,115 controls (subjects without colorectal cancer).

Results and conclusions:
The investigators found the highest quartile of red meat intake was associated with a 41% increased risk of colorectal cancer compared with the lowest quartile [OR = 1.41, 95% CI = 1.29-1.55].
However, a significant association was observed only for studies with retrospective diet data, not for studies with diet prospectively assessed before cancer diagnosis.

The investigators found when combining all studies, high red meat intake was similarly associated with colorectal cancer in those with a rapid/intermediate NAT2 genotype [OR = 1.38, 95% CI = 1.20-1.59] as with a slow genotype [OR = 1.43, 95% CI = 1.28-1.61, p interaction = 0.9].

The investigators concluded high red meat intake was associated with increased risk of colorectal cancer only from retrospective case-control studies and not modified by NAT2 enzyme activity.

Original title:
Red Meat Intake, NAT2, and Risk of Colorectal Cancer: A Pooled Analysis of 11 Studies by Ananthakrishnan AN, Du M, […], Chan AT.

Link:
http://cebp.aacrjournals.org/content/cebp/24/1/198.full.pdf

Additional information of El Mondo:
Find more studies/information on red meat consumption and colorectal cancer right here.